NovaBay Total Current Assets from 2010 to 2024
| NBY Stock | USD 0.08 0 5.33% |
Total Current Assets | First Reported 2005-12-31 | Previous Quarter 8.2 M | Current Value 7.2 M | Quarterly Volatility 3.6 M |
Check NovaBay Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NovaBay main balance sheet or income statement drivers, such as Depreciation And Amortization of 351 K, Interest Expense of 4.6 M or Other Operating Expenses of 16.9 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0555, Dividend Yield of 0.0 or PTB Ratio of 0.25. NovaBay financial statements analysis is a perfect complement when working with NovaBay Pharmaceuticals Valuation or Volatility modules.
NovaBay | Total Current Assets |
Latest NovaBay Pharmaceuticals' Total Current Assets Growth Pattern
Below is the plot of the Total Current Assets of NovaBay Pharmaceuticals over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. NovaBay Pharmaceuticals' Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NovaBay Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Total Current Assets | 10 Years Trend |
|
Total Current Assets |
| Timeline |
NovaBay Total Current Assets Regression Statistics
| Arithmetic Mean | 10,617,383 | |
| Geometric Mean | 9,686,396 | |
| Coefficient Of Variation | 39.98 | |
| Mean Deviation | 3,536,442 | |
| Median | 9,503,747 | |
| Standard Deviation | 4,244,930 | |
| Sample Variance | 18T | |
| Range | 15M | |
| R-Value | (0.06) | |
| Mean Square Error | 19.3T | |
| R-Squared | 0 | |
| Significance | 0.83 | |
| Slope | (58,846) | |
| Total Sum of Squares | 252.3T |
NovaBay Total Current Assets History
About NovaBay Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include NovaBay Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. NovaBay Pharmaceuticals investors use historical funamental indicators, such as NovaBay Pharmaceuticals's Total Current Assets, to determine how well the company is positioned to perform in the future. Although NovaBay Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in NovaBay Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on NovaBay Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on NovaBay Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in NovaBay Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Current Assets | 7.2 M | 9.5 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of NovaBay Pharmaceuticals Correlation against competitors. For more information on how to buy NovaBay Stock please use our How to Invest in NovaBay Pharmaceuticals guide.Note that the NovaBay Pharmaceuticals information on this page should be used as a complementary analysis to other NovaBay Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for NovaBay Stock analysis
When running NovaBay Pharmaceuticals' price analysis, check to measure NovaBay Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBay Pharmaceuticals is operating at the current time. Most of NovaBay Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NovaBay Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBay Pharmaceuticals' price. Additionally, you may evaluate how the addition of NovaBay Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is NovaBay Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NovaBay Pharmaceuticals. If investors know NovaBay will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NovaBay Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.96) | Revenue Per Share 3.494 | Quarterly Revenue Growth 0.023 | Return On Assets (0.25) | Return On Equity (1.39) |
The market value of NovaBay Pharmaceuticals is measured differently than its book value, which is the value of NovaBay that is recorded on the company's balance sheet. Investors also form their own opinion of NovaBay Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is NovaBay Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NovaBay Pharmaceuticals' market value can be influenced by many factors that don't directly affect NovaBay Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NovaBay Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if NovaBay Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NovaBay Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.